Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Cash from Investing Activities (2016 - 2025)

Prestige Consumer Healthcare (PBH) has 16 years of Cash from Investing Activities data on record, last reported at -$128.6 million in Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 1209.7% year-over-year to -$128.6 million; the TTM value through Dec 2025 reached -$136.9 million, down 372.46%, while the annual FY2025 figure was -$17.5 million, 13.22% up from the prior year.
  • Cash from Investing Activities reached -$128.6 million in Q4 2025 per PBH's latest filing, down from -$2.9 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $2.3 million in Q2 2023 and bottomed at -$231.7 million in Q3 2021.
  • Average Cash from Investing Activities over 5 years is -$22.2 million, with a median of -$3.1 million recorded in 2022.
  • Peak YoY movement for Cash from Investing Activities: crashed 2455.33% in 2021, then skyrocketed 321.87% in 2023.
  • A 5-year view of Cash from Investing Activities shows it stood at -$20.2 million in 2021, then surged by 91.09% to -$1.8 million in 2022, then plummeted by 149.36% to -$4.5 million in 2023, then tumbled by 118.33% to -$9.8 million in 2024, then plummeted by 1209.7% to -$128.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Investing Activities were -$128.6 million in Q4 2025, -$2.9 million in Q3 2025, and -$1.9 million in Q2 2025.